David Ginsburg

Title: David Ginsburg: Innovator in Medical Research

Introduction

David Ginsburg is a prominent inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of medical research, particularly in the development of therapeutic agents against bacterial infections. With a total of 10 patents to his name, Ginsburg's work has had a substantial impact on healthcare.

Latest Patents

Among his latest patents are innovative methods and compositions for treating bacterial infections. This invention relates to chemical compounds and methods for their discovery, providing therapeutic agents against bacterial infections, including biofilms. Another notable patent involves DNA encoding Von Willebrand Factor (VWF) and methods for producing VWF. This patent outlines the use of an expression vector that includes a DNA sequence encoding a functional VWF protein, along with regulatory DNA for effective expression in host cells. Additionally, the gene for VWF is localized to the short arm of human chromosome 12 (12p), and restriction fragment length polymorphisms (RFLPs) associated with the VWF gene are identified for use in probes.

Career Highlights

David Ginsburg has worked with esteemed institutions such as the University of Michigan and Henry Ford Health System. His research has focused on advancing medical treatments and understanding genetic factors related to blood disorders.

Collaborations

Ginsburg has collaborated with notable colleagues, including Gallia Levy and Han-Mou Tsai, contributing to a rich exchange of ideas and innovations in his field.

Conclusion

David Ginsburg's work exemplifies the spirit of innovation in medical research. His patents and collaborations continue to pave the way for advancements in the treatment of bacterial infections and genetic disorders.